Patent Evaluator definition

Patent Evaluator means individuals or firms that have been certified by the PatentBook Administrator or an entity approved by the PatentBook Administrator to provide such certification to perform elements of Publisher's Evaluations and Validations as set forth in Section 3.4.2 and the Patent Evaluation Criteria.
Patent Evaluator means the independent patent evaluator for the Via-administered LTE licensing program.

Examples of Patent Evaluator in a sentence

  • Publisher (Licensor) shall provide each such Evaluation to the PatentBook Administrator, along with a written request that the PatentBook Administrator have such Patent(s) Evaluation(s) validated (a "Validation") by an independent Patent Evaluator, resulting in a validated numerical score.

  • If the Publisher (Licensor) has had the Evaluation performed by an independent Patent Evaluator, a different independent Patent Evaluator selected by the PatentBook Administrator shall perform the Validation.

  • An independent Patent Evaluator shall perform each Validation of a Patent Evaluation.

  • In such event, if the challenging Person desires to have a Patent Evaluator evaluate or re-evaluate the Challenged Patent, the Publisher (Licensor) shall submit the Challenged Patent and any supporting documentation to a Patent Evaluator for re-evaluation, provided the challenging Person pays all fees and expenses of the Patent Evaluator.

  • If the Evaluation and Validation of the challenge patent confirms the patent is in the right Tier and should not be re-assigned to a lower Tier, the Patent Evaluator fees will be paid by the PatentBook Administrator.

  • The Publisher (Licensor) of the Challenged Patent shall be responsible for the Patent Evaluator fee incurred in connection with the re-evaluation of the Challenged Patent under this Subsection if the Evaluation confirms the re-classification of the patent into a lower tier.

  • III.6.1. The PatentBook Administrator shall promptly notify Publisher (Licensor) regarding its patents upon completion of any Evaluation by a Patent Evaluator, as well as any determination by PatentBook Administrator of Patent Tier classification or re-classification.

  • Licensee acknowledges that Licensor, in its sole discretion, may provide the Patent Evaluator claim charts and other materials to support its belief that the Asserted Licensee Patent is an Essential LTE Patent.

Related to Patent Evaluator

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Therapeutic school means a residential group living facility:

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Non-Microsoft Product means any third-party-branded software, data, service, website or product, unless incorporated by Microsoft in a Product.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • scientific research means any activity in the field of natural or applied science for the extension of knowledge;

  • Collaborator An individual who is not under the direct supervision of the PI (e.g., not a member of the PI’s laboratory) who assists with the PI’s research project involving controlled-access data subject to the NIH GDS Policy. Internal collaborators are employees of the Requester and work at the same location/campus as the PI. External collaborators are not employees of the Requester and/or do not work at the same location as the PI, and consequently must be independently approved to access controlled-access data subject to the NIH GDS Policy.

  • Product Patents means any and all United States patents and patent applications, all divisionals, continuations, continuations-in-part, re-issues, extensions or foreign counterparts thereof, now or hereafter owned or controlled ("controlled" being used in the sense of having the right to grant licenses thereunder) by PERIMMUNE, covering the manufacture, use, sale, offer for sale and/or importation of the Product, including but not limited to, the U.S. Patent No. 5,407,912 attached hereto as Exhibit B.

  • ISIS means the department’s individualized services information system.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Manufacturing Know-How means all information, techniques, inventions, discoveries, improvements, practices, methods, knowledge, skill, experience and other technology, whether or not patentable or copyrightable, and any copyrights based thereon, relating to or necessary or useful for the production, purification, packaging, storage and transportation of Collaboration Products, including without limitation specifications, acceptance criteria, manufacturing batch records, standard operating procedures, engineering plans, installation, operation and process qualification protocols for equipment, validation records, master files submitted to the FDA, process validation reports, environmental monitoring processes, test data including pharmacological, toxicological and clinical test data, cost data and employee training materials.

  • Program Technology means Program Know-How and Program Patents.

  • Patent Cooperation Treaty means the Patent Cooperation Treaty done at Washington on June 19, 1970;

  • Merck has the meaning set forth in the preamble.

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Patent Rights means all patents and patent applications, including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, extensions, registrations, and supplemental protection certificates and the like of any of the foregoing.

  • Licensee has the meaning set forth in the preamble.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Patent Application means an application for patent protection for a CRADA Subject Invention with the United States Patent and Trademark Office (“U.S.P.T.O.”) or the corresponding patent-issuing authority of another nation.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • GSK has the meaning set forth in the preamble.